Halozyme Therapeutics
HALO
#2002
Rank
A$11.99 B
Marketcap
$94.72
Share price
1.36%
Change (1 day)
55.29%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.62

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $2.61. In 2022 the company made an earnings per share (EPS) of $2.22 a decrease over its 2021 EPS that were of $4.27.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.6218.02%
2022$2.22-48.07%
2021$4.27196.88%
2020$1.44-292%
2019-$0.75-9.09%
2018-$0.82-237.5%
2017$0.60-149.38%
2016-$1.21211.54%
2015-$0.39-52.73%
2014-$0.82-24.66%
2013-$1.0948.98%
2012-$0.73145%
2011-$0.30-64.29%
2010-$0.84-17.65%
2009-$1.029.68%
2008-$0.9393.75%
2007-$0.4833.33%
2006-$0.36-4%
2005-$0.37-3.85%
2004-$0.39-13.33%
2003-$0.4583.59%
2002-$0.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.28-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.14 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.68 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.77 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$21.13 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA